[ad_1]
Revenue has issued a tax bill of 1.6 billion euros to a large pharmaceutical group.
The valuation is the second largest in Irish history after the conviction of Apple to pay 13 billion euros in 2016.
The tax bill served to the Dublin-based Perrigo pharmaceutical company concerns Elan, a company bought by Perrigo five years ago.
Elan sold his interest in a multiple sclerosis drug in 2013 to a company called Biogen for an upfront payment of $ 3.25 billion and a share of future royalties.
According to the Irish Times, the company said the profits from the transaction were paid at the rate of 12.5% of the corporate tax.
Revenue argues however that Elan was liable for the capital gains tax rate of 33%.
Perrigo said that he did not agree with Revenue and that he intended to challenge the bill.
Source link
